HUTCHMED (China) (HMDCF) Inventory (2015 - 2026)
HUTCHMED (China)'s (HMDCF) quarterly Inventory came in at $40.8 million in Q2 2026, down 15.71% year-over-year from $48.5 million in Q2 2025, and down 0.7% quarter-over-quarter from $41.1 million in Q4 2025.
Analysis
HUTCHMED (China) (HMDCF) Inventory (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Inventory for 12 consecutive years, with $40.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Inventory fell 15.71% year-over-year to $40.8 million in Q2 2026; TTM through Jun 2026 was $40.8 million, a 15.71% decrease from a year earlier, with the FY2025 full-year figure at $41.1 million, changed N/A from the prior year.
- Inventory was $40.8 million for Q2 2026 at HUTCHMED (China), down from $41.1 million in the prior quarter.
- Over five years, Inventory peaked at $56.7 million in Q4 2022 and troughed at $40.8 million in Q2 2026.
- A 5-year average of $47.6 million and a median of $46.4 million in 2024 frame the typical range for Inventory.
- Across the five-year window, Inventory surged 80.06% in 2022 and slipped 15.71% in 2026, its largest moves.
- Over 5 years, Inventory stood at $56.7 million in 2022, then fell by 4.97% to $53.9 million in 2023, then dropped by 13.8% to $46.4 million in 2024, then declined by 11.44% to $41.1 million in 2025, then dropped by 0.7% to $40.8 million in 2026.
- The last three Inventory figures came in at $40.8 million (Q2 2026), $41.1 million (Q4 2025), and $48.5 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn | 6.22 Bn |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn | 1.95 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn | 3.08 Bn |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn | 371.00 Mn |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn | 280.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn | 2.38 Bn |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn | - |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | 40.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.84 Mn |
| Dec 31, 2025 | 41.13 Mn |
| Jun 30, 2025 | 48.45 Mn |
| Jun 30, 2024 | 46.44 Mn |
| Jun 30, 2023 | 53.88 Mn |
| Dec 31, 2022 | 56.69 Mn |
| Jun 30, 2022 | 45.93 Mn |
| Dec 31, 2021 | 35.76 Mn |
| Jun 30, 2021 | 25.51 Mn |
| Mar 31, 2021 | 19.76 Mn |
| Dec 31, 2020 | 19.77 Mn |
| Jun 30, 2020 | 15.26 Mn |
| Dec 31, 2019 | 16.21 Mn |
| Sep 30, 2019 | 15.65 Mn |
| Jun 30, 2019 | 14.22 Mn |
| Mar 31, 2019 | 17.61 Mn |
| Dec 31, 2018 | 557,000.00 |
| Jun 30, 2018 | 9.79 Mn |
| Dec 31, 2017 | 1.05 Mn |
| Jun 30, 2017 | 10.69 Mn |